logo
episode-header-image
Nov 2022
3m 19s

Podcast 831: O2 Targets

EMERGENCY MEDICAL MINUTE
About this episode

Contributor: Aaron Lessen,MD

Educational Pearls:

  • Recent study looked at mechanically ventilated patients in ED and ICU to determine if O2 saturation level impacted patient outcomes
    • 2541 patients randomized to one of three target O2 saturation levels
      • Low: 90% (Range: 88-92%)
      • Intermediate: 94% (Range: 92-96%)
      • High: 98% (Range: 96-100%)
    • Outcome indicators
      • Primary: Number of days alive and ventilator free by day 28 of hospital admission
      • Secondary: Mortality at 28 days
    • No significant difference was seen for either primary or secondary outcomes between all three groups at 28 days
  • This study shows that the target oxygenation level  is not likely to significantly impact outcomes in mechanically ventilated patients in the ED

 

References

Semler MW, Casey JD, Lloyd BD, et al. Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation. N Engl J Med. Nov 10 2022;387(19):1759-1769. doi:10.1056/NEJMoa2208415

 

Summarized by Mark O’Brien, MS4 | Edited by John Spartz, MD, & Erik Verzemnieks, MD

In an effort to promote diversity, equity, and inclusion in Emergency Medicine, The Emergency Medical Minute is proud to present our 2nd annual Diversity and Inclusion Award. We support increasing the representation of underrepresented groups in medicine and extend this award to individuals applying to emergency medicine residencies during the 2022-2023 cycle. For information on award eligibility and the application process, visit https://emergencymedicalminute.com/edi-award/

Donate to EMM today!

Up next
Mar 2025
Episode 946: Time to Defibrillation
Contributor: Aaron Lessen, MD Educational Pearls: Quick background info Cardiac arrest is when the heart stops pumping blood for any reason. This is different from a heart attack in which the heart is still working but the muscle itself is starting to die. One cause of cardiac ar ... Show More
2m 30s
Feb 2025
Episode 945: Ketorolac vs. Ibuprofen
Contributor: Ricky Dhaliwal, MD Educational Pearls:  Ketorolac and ibuprofen are NSAIDs with equivalent efficacy for pain in the emergency department Oral ibuprofen provides the same relief as intramuscular ketorolac IM ketorolac is associated with the adverse effect of a painful ... Show More
3m 30s
Feb 2025
Episode 944: Colchicine Overdose
Contributor: Aaron Lessen, MD Educational Pearls: Colchicine is most commonly used for the prevention and treatment of gout There is research investigating the anti-inflammatory and cardioprotective effects of colchicine  This drug has a narrow therapeutic index: a small margin b ... Show More
3m 19s
Recommended Episodes
Jun 2024
Day 2: Top Takeaways From ASCO24
Dr. John Sweetenham shares highlights from Day 2 of the 2024 ASCO Annual Meeting, including potentially practice-changing results in advanced Hodgkin lymphoma, intriguing data on the effect of metformin on active surveillance for prostate cancer, and the potential of AI to improv ... Show More
10m 15s
May 2024
Day 1: Top Takeaways From ASCO24
In the first episode of a special daily series during the 2024 ASCO Annual Meeting, Dr. John Sweetenham shares highlights from Day 1, including exciting data on the CROWN trial in NSCLC, the ASC4First study in chronic myeloid leukemia, and the effects of high-deductible health pl ... Show More
10m 35s
Apr 2024
Episode 195: ARDS
We review Acute Respiratory Distress Syndrome Hosts: Sadakat Chowdhury, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/ARDS.mp3 Download Leave a Comment Tags: Critical Care, Pulmonary Show Notes Definition of ARDS: Non-cardiogenic pulmonary edem ... Show More
14m 59s
Aug 2022
Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes from the NADIM II trial. In that trial, patie ... Show More
9m 32s
Jun 2024
Day 3: Top Takeaways from ASCO24
Dr. John Sweetenham shares highlights from Day 3 of the 2024 ASCO Annual Meeting, including selected studies on the treatment of cancer cachexia, surgical approaches in advanced ovarian cancer, and advanced colorectal cancer with liver metastases. TRANSCRIPT Dr. John Sweetenham: ... Show More
11m 57s
Feb 2023
Freely Filtered 056: MyTEMP
The Filtrate:Joel TopfSwapnil HiremathNayan AroraSophia AmbrusoWith Special Guest:Amit Garg @AmitXGarg, Nephrologist at Western University, London, and lead PI of the MYTEMP trial. Editor:Joel TopfShow Notes:MyTEMP in pubmed: Personalised cooler dialysate for patients receiving m ... Show More
1h 21m
Nov 2023
Freely Filtered 064: Freely Filtered with The Curbsiders Live at Kidney Week!
The Filtrate:Joel TopfSwapnil HiremathSophia AmbrusoAC GomezJosh WaitzmanJennie LinNayan AroraThe CurbsidersMatt F. Watto (@DoctorWatto)Paul Nelson Williams, America’s primary care physician (@PaulNWilliamz)With Special Guest:JD Foster (@KidneyVet)Sayed Tabatabai (@TheRealDoctorT ... Show More
1h 32m
Oct 2023
#498: The PROPEL Trial & Weight Loss Interventions in Primary Care – John Apolzan, PhD
Links: Subscribe to PREMIUM Go to episode page (with linked studies) Receive the weekly Sigma email newsletter Recommended resources About this Episode: The PROPEL (Promoting Successful Weight Loss in Primary Care in Louisiana) trial was a cluster-randomized weight loss trial, sp ... Show More
35m 39s
Oct 2020
#236 Approach to Shortness of Breath: Physical Exam Series
Learn which exam maneuvers are worthwhile and which ones are worthless in your approach to shortness of breath. In our evidence based series on the physical exam, we discuss the approach to the dyspneic patient with Dr. Brian Garibaldi (Hopkins, SBM), associate professor of pulmo ... Show More
41m 28s